Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer

Published:2019-10 Issue: Volume:118 Page:109374
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Fu Wei,Hong Zhiming,You Xujun,Din Jing,Chen Baishu,Zhao Beibei,Yuan Gengyan,Li Qixin

Funder

Shenzhen Science and Technology Plan Project

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. PSA decline is an independent prognostic marker in hormonally treated prostate cancer;Palmberg;Eur. Urol.,1999

3. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer;Walsh;J. Urol.,2005

4. Castration-resistant prostate cancer: AUA guideline amendment 2018;Lowrance;J. Urol.,2018

5. Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects;Pronk;Cancer Treat. Rev.,1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calotropis procera extract inhibits prostate cancer through regulation of autophagy;Journal of Cellular and Molecular Medicine;2024-02-23

2. Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS/miR-214-3p/CCL5 pathway;Asian Journal of Andrology;2023-11-14

3. Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice;Chinese Herbal Medicines;2023-10

4. Based on Network Pharmacology-Quercetin, a Component of Fuzheng Yiliu Decoction Suppressed Prostate Cancer by Regulating PI3K/AKT Pathway;Andrologia;2023-05-27

5. Role of microRNA-34b-5p in cancer and injury: how does it work?;Cancer Cell International;2022-12-01